Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Vectura Group PLC (VEC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Vectura historical data, for real-time data please try another search
164.80 0.00    0.00%
18/10 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 164.60 / 165.00
  • Day's Range: 164.80 - 165.00
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BKM2MW97 
SEDOL:  BKM2MW9
Vectura 164.80 0.00 0.00%

VEC Balance Sheet

 
Assess the latest Vectura balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced VEC Annual Report data, financial summaries and charts are available for Vectura Group PLC investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2020
31/12
2020
30/06
2019
31/12
2019
30/06
Total Current Assets 305.6 148.9 146.1 169.8
Cash and Short Term Investments 78.6 81.9 74.1 105.9
Cash - - - -
Cash & Equivalents 78.6 81.9 74.1 105.9
Short Term Investments - - - -
Total Receivables, Net 198.2 35 44.3 38
Accounts Receivables - Trade, Net 198.2 35 44.3 38
Total Inventory 28.8 32 27.7 25.9
Prepaid Expenses - - - -
Other Current Assets, Total - - - -
Total Assets 666 546.4 530.7 594.5
Property/Plant/Equipment, Total - Net 56.4 60.6 55.1 59.8
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 149.6 166.4 162.2 163.8
Intangibles, Net 150.1 167 164.1 191.6
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 4.3 3.5 3.2 9.5
Other Assets, Total - - - -
Total Current Liabilities 85.2 59.1 64.1 59.8
Accounts Payable - - - -
Payable/Accrued 64.6 46.7 48.8 47.2
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1.2 1.4 1.2 1.2
Other Current liabilities, Total 19.4 11 14.1 11.4
Total Liabilities 121.6 111 111.3 114.9
Total Long Term Debt 3 7.2 6.4 7.1
Long Term Debt - 7.2 3.8 4
Capital Lease Obligations 3 - 2.6 3.1
Deferred Income Tax 27.2 30.9 28.4 35
Minority Interest - - - -
Other Liabilities, Total 6.2 13.8 12.4 13
Total Equity 544.4 435.4 419.4 479.6
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.2 0.2 0.2 0.2
Additional Paid-In Capital 61.7 61.7 61.6 61.6
Retained Earnings (Accumulated Deficit) 438.7 323.8 329.9 382.5
Treasury Stock - Common -2.4 -2.9 -2.3 -2.6
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 46.2 52.6 30 37.9
Total Liabilities & Shareholders' Equity 666 546.4 530.7 594.5
Total Common Shares Outstanding 595.96 602.3 611.5 615.05
Total Preferred Shares Outstanding 0.03 0.03 0.03 0.03
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VEC Price Commentary

Write your thoughts about Vectura Group PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Hamilton
Mike Hamilton May 26, 2021 12:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
£958 million takeover yesterday by Carlyle Group.
yash kanabar
yash kanabar Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone know why the share popped 13% today?
Mark Hopkin
Mark Hopkin Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glaxo denied appeal.
Mark Hopkin
Mark Hopkin Nov 19, 2020 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glaxo denied appeal.
Arvinder Mann
ARVI Oct 30, 2020 8:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email